Chronix Biomedical, Inc. – Trademark Portfolio

Entity Type: 03

Chronix Biomedical, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include THERASURE. The owner is based in San Jose, CA.

5941 Optical Court, Suite 203E

San Jose, CA 95138

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Chronix Biomedical, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (4 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Chronix Biomedical, Inc. have?

Chronix Biomedical, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 7 abandoned.

What trademark classes does Chronix Biomedical, Inc. file in?

Chronix Biomedical, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are Chronix Biomedical, Inc.'s most well-known trademarks?

Chronix Biomedical, Inc.'s registered trademark portfolio includes well-known marks such as THERASURE. These are among 1 currently registered trademark in the portfolio.

What is Chronix Biomedical, Inc.'s trademark registration success rate?

Chronix Biomedical, Inc. has a 13% trademark registration rate, with 1 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.